October 14, 2024
XBiotech: Several Shots On Goal In Big Target Market Indications (NASDAQ:XBIT)

chemistry fume hoods in a typical modern chemistry laboratory

Bo Shen/iStock via Getty Images

XBiotech Inc. (NASDAQ:XBIT) has been able to complete recruitment for a few studies already, and it has initiated another one targeting patients with Rheumatoid arthritis [RA]. Natrunix is being developed to treat patients with RA and

link

Leave a Reply

Your email address will not be published. Required fields are marked *